Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Neisseria meningitidis Stories

2014-04-23 08:29:49

Signs and Prevention of Meningitis that Every College-Bound Student Should Know TOPEKA, Kan., April 23, 2014 /PRNewswire/ -- In the spring of 2004, Andy Marso was preparing to graduate from the University of Kansas with a journalism degree. One night he went to bed early with flu-like symptoms. The next morning he could not walk and there was a strange purple rash on his arms. By that night he was in intensive care, flown by helicopter to the university's medical center in septic...

2014-02-09 04:20:17

LONDON, February 9, 2014 /PRNewswire/ -- INTERNATIONAL photographer and artist Anne Geddes invites us to take a fresh look at disability, with three new thought-provoking portraits of UK children who have lost limbs to meningitis. (Photo: http://photos.prnewswire.com/prnh/20140209/668113-a ) (Photo: http://photos.prnewswire.com/prnh/20140209/668113-b ) (Photo: http://photos.prnewswire.com/prnh/20140209/668113-c ) Amber Travers (5),...

2014-01-08 17:32:42

A special issue on sepsis has been released by the publisher Landes Bioscience (Austin, TX USA). The articles contained in this special issue of the journal Virulence have been authored by world-class investigators and provide new insights into both the pathogen-related factors and the host defense mechanisms that lead to septic shock and contribute to its resolution or fatal outcome. Sepsis, or septic shock, is an excessive inflammatory response in answer to a serious infection, most...

2013-12-26 08:23:12

LONDON, Dec. 26, 2013 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 SummaryMeningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these...

2013-12-26 08:23:10

LONDON, Dec. 26, 2013 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 SummaryMeningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons...

2013-12-26 08:23:07

LONDON, Dec. 26, 2013 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 SummaryMeningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons the...

2013-12-19 16:27:25

LONDON, Dec. 19, 2013 /PRNewswire/ -- Reportbuyer.com just published a new market research report:PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, "PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022". Meningococcal disease is an acute infection caused by the gram-negative bacterium...

2013-11-18 20:21:08

ATLANTA, Nov. 18, 2013 /PRNewswire/ -- Princeton University announced plans for the use of Bexsero® meningococcal B vaccine in response to the meningococcal disease outbreak at the University. The National Meningitis Association (NMA) supports this collaborative public health effort that will help protect those at Princeton during this time of high-risk for the infection. Quick Facts about Meningococcal Disease and Vaccination -- Meningococcal disease, which is sometimes called...

2013-09-13 08:19:19

No cases of serogroup A meningococcal meningitis following vaccination of almost 2 million people; incidence of all cases of meningitis reduced by 94 percent Evaluation of the effectiveness of a mass vaccination campaign with a new meningitis serogroup A vaccine, PsA-TT, in sub-Saharan Africa found that it had a dramatic impact on cases of serogroup meningitis and on carriage of the disease-causing bacteria in the throat, according to new research published in The Lancet. Authors from...

2013-08-05 12:28:04

HOUSTON, Aug. 5, 2013 /PRNewswire-USNewswire/ -- Meningitis Angels are celebrating the announcement of the U.S. Food and Drug Administration's (FDA) expanded approval of Menveo, a vaccine used to help prevent meningococcal disease caused by four strains (A,C,Y, W-135) of the bacterium Neisseria meningitidis (N. meningitidis). The vaccine is now approved for use in infants and toddlers starting as early as 2 months of age. Meningococcal disease is an aggressive, fast-acting illness...


Latest Neisseria meningitidis Reference Libraries

72_d0e074525de5bb741daf382f8d62213f
2011-04-25 16:38:12

Neisseria meningitidis is a heterotrophic gram-negative diplococcal bacterium best known for its role in meningitis and other forms of meningococcal disease such as meningococcemia. It is a major cause of morbidity and mortality during childhood in industrialized countries and is responsible for epidemics in Africa and in Asia. In the US there are approximately 2500 to 3500 cases of N. meningitides infections. Children under 5 are at a higher risk as well as people in the sub-Saharan...

More Articles (1 articles) »